Pliant Therapeutics Inc (NASDAQ:PLRX) has a beta value of 1.47 and has seen 1.19 million shares traded in the recent trading session. The company, currently valued at $80.21M, closed the recent trade at $1.31 per share which meant it lost -$0.04 on the day or -2.98% during that session. The PLRX stock price is -1161.07% off its 52-week high price of $16.52 and 3.82% above the 52-week low of $1.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.92 million shares traded. The 3-month trading volume is 2.64 million shares.
The consensus among analysts is that Pliant Therapeutics Inc (PLRX) is Buy stock at the moment, with a recommendation rating of 2.69. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.75.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Sporting -2.98% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PLRX stock price touched $1.31 or saw a rise of 16.03%. Year-to-date, Pliant Therapeutics Inc shares have moved -90.05%, while the 5-day performance has seen it change -12.09%. Over the past 30 days, the shares of Pliant Therapeutics Inc (NASDAQ:PLRX) have changed -5.09%. Short interest in the company has seen 3.98 million shares shorted with days to cover at 1.07.
Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump 47.6% from the levels at last check today. The projected low price target is $2.0 while the price target rests at a high of $3.0. In that case, then, we find that the latest price level in today’s session is -129.01% off the targeted high while a plunge would see the stock gain -52.67% from the levels at last check today.
Pliant Therapeutics Inc (PLRX) estimates and forecasts
The company’s shares have lost -88.42% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -78.30% over the past 5 years. Earnings growth for 2025 is a modest 23.99% while over the next 5 years, the company’s earnings are expected to increase by 16.00%.
PLRX Dividends
Pliant Therapeutics Inc is expected to release its next earnings report on 2025-Mar-02 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Pliant Therapeutics Inc (NASDAQ:PLRX)’s Major holders
Insiders own 3.27% of the company shares, while shares held by institutions stand at 117.05% with a share float percentage of 121.01%. Investors are also buoyed by the number of investors in a company, with Pliant Therapeutics Inc having a total of 235.0 institutions that hold shares in the company. The top two institutional holders are DEEP TRACK CAPITAL, LP with over 5.97 million shares worth more than $64.2 million. As of 2024-06-30, DEEP TRACK CAPITAL, LP held 9.8907% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 4.97 million shares as of 2024-06-30. The firm’s total holdings are worth over $53.45 million and represent 8.2335% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are T. Rowe Price New Horizons Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 3.82% shares in the company for having 2.34 shares of worth $3.08 million while later fund manager owns 1.79 shares of worth $2.35 million as of Dec 31, 2024, which makes it owner of about 2.92% of company’s outstanding stock.
